Nutritional status of children with solid tumors

Cancer

Volumn 86, Issue 1, 1999, Pages 119-125

  Elhasid, Ronit ^a   Laor, Arie ^b,c   Lischinsky, Sophie ^a   Postovsky, Sergey ^a   Arush, Myriam Weyl Ben ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

Children; Nutritional status; Prealbumin; Solid tumors

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; PREALBUMIN;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; SOLID TUMOR; WEIGHT REDUCTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; NUTRITIONAL STATUS; PREALBUMIN; PROSPECTIVE STUDIES; PROTEIN DEFICIENCY; SERUM ALBUMIN;

EID: 0033168468     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990701)86:1<119::AID-CNCR17>3.0.CO;2-X     Document Type: Article

References (38)

1. Tyc VL, Vallelunga L, Mahoney S, Smith BF, Mulhern RK. Nutritional and treatment-related characteristics of pediatric oncology patients referred or not referred for nutritional support. Med Pediatr Oncol 1995;25:379-88.
2. Mauer AM, Burgess JB, Donaldson SS, Rickard KA, Stallings VA, van Eys J, et al. Special nutritional needs of children with malignancies: a review. JPEN J Parenter Enteral Nutr 1990; 14:315-24.
3. Rickard KA, Coates TD, Grosfeld JL, Weetman RM, Baehner RL. The value of nutrition support in children with cancer. Cancer 1986;58:1904-10.
4. Carter P, Carr D, van Eys J, Coody D. Nutritional parameters in children with cancer. J Am Diet Assoc 1983;82:616-22.
5. Smith DE, Stevens MCG, Booth IW. Malnutrition at diagnosis of malignancy in childhood: common but mostly missed. Eur J Pediatr 1991;150:318-22.
6. Alexander HR, Rickard KA, Godshall B. Nutritional supportive care. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 3rd edition. Philadelphia: Lippincott-Raven, 1997:1167-79.
7. Bonadonna G, Valagussa P, Santoro A. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. Ann Intern Med 1986;104:739-46.
8. Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, et al. Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol 1994;7:339-48.
9. Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Münster group. J Clin Oncol 1995;13:359-72.
10. Pinkerton CR, Pritchard J, Spitz L. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. J Clin Oncol 1986;4:194-9.
11. Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O Jr., Vietti TJ, et al. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study. J Clin Oncol 1991; 9:1173-80.
12. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-30.
13. Weyl Ben Arush M, Stein ME, Kuten A, Meller I, Moses M, Drumea K, et al. Postsurgical etoposide-ifosfamide regimen in poor-risk nonmetastatic osteogenic sarcoma. Am J Clin Oncol 1998;21:72-4.
14. Stram DO, Matthay KK, O'Leary M, Reynolds CR, Haase GM, Atkinson JB, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 1996;14:2417-26.
15. Nitschke R, Smith EI, Altshuler G, Altmiller D, Shuster J, Green A, et al. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991;9:1181-8.
16. Cairo MS. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors. Semin Oncol 1995;22(3 Suppl 7):23-7.
17. Kushner BH, LaQuaglia MP, Bonilla MA, Lindsley K, Rosenfield N, Yeh S, et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 1994;12:2607-13.
18. Pratt CB, Crom DB, Howarth C. The use of chemotherapy for extraocular retinoblastoma. Med Pediatr Oncol 1985;13: 330-3.
19. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328: 1725-31.
20. Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar-primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 1996;34: 899-904.
21. Green DM, Breslow NE, Evans I, Moksness J, Finklestein JZ, Evans AE, et al. The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study. Am J Pediatr Hematol Oncol 1994;16:207-12.
22. Woolley P, Smith F, Esteves R, Gisselbrecht C, Alvarez C, Boiron M, et al. A phase II trial of 5-FU, Adriamycin and cisplatin (FAP) in advanced gastric cancer [abstract]. In: Proceedings of the 72nd Annual Meeting of the American Association for Cancer Research and the 17th Annual Meeting of the American Society of Clinical Oncology, Washington, DC, April 30-May 2,1981;22:455.
23. SAS Institute, Inc. SAS for personal computers. Release 6.12. Cary, NC: SAS Institute, Inc., 1997.
24. van Eys J. Nutrition and cancer: physiological interrelationships. Annu Rev Nutr 1985;5:435-61.
25. van Eys J. Malnutrition in children with cancer. Incidence and consequence. Cancer 1979;43:2030-5.
26. DeWys WD, Begg D, Lavin PT, Band PBR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-7.
27. Donaldson SS, Wesley MN, De Wys WD, Suskind RM, Jaffe N, VanEys J. A study of the nutritional status of pediatric cancer patients. Am J Dis Child 1981;135:1107-12.
28. Kurugöl Z, Egemen A, Ceting̈ul N, Öztop S, Kavakli K, Nisli G. Nutritional status of children with leukemia [letter]. Med Pediatr Oncol 1997;28:321-2.
29. Yu LC, Kuvibidila S, Ducos R, Warrier RP. Nutritional status of children with leukemia. Med Pediatr Oncol 1994; 22:73-7.
30. Ogunshina SO, Hussain MA. Plasma thyroxine binding prealbumin as an index of mild protein-energy malnutrition in Nigerian children. Am J Clin Nutr 1980;33:794-800.
31. Uderzo C, Rovelli A, Bonomi M, Fomia L, Pirovano L, Masera G. Total parenteral nutrition and nutritional assessment in leukaemic children undergoing bone marrow transplantation. Eur J Cancer 1991;27:758-62.
32. Prealbumin in Nutritional Care Consensus Group. Measurement of visceral protein status in assessing protein and energy malnutrition: standard of care. Nutrition 1995;11:169-71.
33. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994;14:495-533.
34. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992;89:1681-4.
35. Matthys P, Dijkmans R, Proost P, Van Damme J, Heremans H, Sobis H, et al. Severe cachexia in mice inoculated with interferon-γ-producing tumor cells. Int J Cancer 1991;49:77-82.
36. Roe S, Cooper AL, Morris ID, Rothwell NJ. Mechanisms of cachexia induced by T-cell leukemia in the rat. Metabolism 1996;45:645-51.
37. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986;320: 584-8.
38. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996;379:739-42.